References
- Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34(11):2363–2371. doi:https://doi.org/10.1161/ATVBAHA.114.304488.
- Anderson FA Jr., Wheeler HB, Goldberg RJ, et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med. 1991;151(5):933–938. doi:https://doi.org/10.1001/archinte.1991.00400050081016.
- Spencer FA, Emery C, Joffe SW, et al. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis. 2009;28(4):401–409. doi:https://doi.org/10.1007/s11239-009-0378-3.
- Wendelboe AM, Raskob GE. Global Burden of Thrombosis: Epidemiologic Aspects. Circ Res. 2016;118(9):1340–1347.
- Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386–1389.
- Stein PD, Henry JW. Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest. 1995;108(4):978–981.
- Barco S, Mahmoudpour SH, Valerio L, et al. Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med. 2020;8(3):277–287. doi:https://doi.org/10.1016/S2213-2600(19)30354-6.
- Keller K, Hobohm L, Ebner M, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J. 2020;41(4):522–529. doi:https://doi.org/10.1093/eurheartj/ehz236.
- de Miguel-Diez J, Jimenez-Garcia R, Jimenez D, et al. Trends in hospital admissions for pulmonary embolism in Spain from 2002 to 2011. Eur Respir J. 2014;44(4):942–950. doi:https://doi.org/10.1183/09031936.00194213.
- Dentali F, Ageno W, Pomero F, et al. Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy. Thromb Haemost. 2016;115(2):399–405.
- Lehnert P, Lange T, Moller CH, et al. Acute Pulmonary Embolism in a National Danish Cohort: Increasing Incidence and Decreasing Mortality. Thromb Haemost. 2018;118(3):539–546.
- Jimenez D, de Miguel-Diez J, Guijarro R, et al. Trends in the Management and Outcomes of Acute Pulmonary Embolism: Analysis From the RIETE Registry. J Am Coll Cardiol. 2016;67(2):162–170. doi:https://doi.org/10.1016/j.jacc.2015.10.060.
- Roy PM, Meyer G, Vielle B, et al. Appropriateness of diagnostic management and outcomes of suspected pulmonary embolism. Ann Intern Med. 2006;144(3):157–164. doi:https://doi.org/10.7326/0003-4819-144-3-200602070-00003.
- Jimenez D, Bikdeli B, Barrios D, et al. Management appropriateness and outcomes of patients with acute pulmonary embolism. Eur Respir J. 2018;51(5):1800445. doi:https://doi.org/10.1183/13993003.00445-2018.
- Wiener RS, Schwartz LM, Woloshin S. Time trends in pulmonary embolism in the United States: evidence of overdiagnosis. Arch Intern Med. 2011;171(9):831–837.
- Casazza F, Becattini C, Bongarzoni A, et al. Clinical features and short term outcomes of patients with acute pulmonary embolism. The Italian Pulmonary Embolism Registry (IPER). Thromb Res. 2012;130(6):847–852.
- Meyer G, Vicaut E, Danays T, et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med. 2014;370(15):1402–1411. doi:https://doi.org/10.1056/NEJMoa1302097.
- Kasper W, Konstantinides S, Geibel A, et al. Management strategies and determinants of outcome in acute major pulmonary embolism: results of a multicenter registry. J Am Coll Cardiol. 1997;30(5):1165–1171. doi:https://doi.org/10.1016/S0735-1097(97)00319-7.
- White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4–8.
- Geibel A, Zehender M, Kasper W, et al. Prognostic value of the ECG on admission in patients with acute major pulmonary embolism. Eur Respir J. 2005;25(5):843–848.
- Hobohm L, Becattini C, Ebner M, et al. Definition of tachycardia for risk stratification of pulmonary embolism. Eur J Intern Med. 2020;82:76–82.
- Jaureguizar A, Jimenez D, Bikdeli B, et al. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism. Chest. 2021;161(2):524–534. doi:https://doi.org/10.1016/j.chest.2021.08.059.
- Barco S, Vicaut E, Klok FA, et al. Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials. Eur Respir J. 2018;51(1):1701775. doi:https://doi.org/10.1183/13993003.01775-2017.
- Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041–1046. doi:https://doi.org/10.1164/rccm.200506-862OC.
- Jimenez D, Aujesky D, Moores L, et al. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170(15):1383–1389. doi:https://doi.org/10.1001/archinternmed.2010.199.
- Vedovati MC, Cimini LA, Pierpaoli L, et al. Prognostic value of respiratory index in haemodynamically stable patients with acute pulmonary embolism: The Respiratory Index model study. Eur Heart J Acute Cardiovasc Care. 2020;9(4):286–292. doi:https://doi.org/10.1177/2048872620913849.
- Barco S, Ende-Verhaar YM, Becattini C, et al. Differential impact of syncope on the prognosis of patients with acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2018;39(47):4186–4195. doi:https://doi.org/10.1093/eurheartj/ehy631.
- Heit JA, Silverstein MD, Mohr DN, et al. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159(5):445–453. 3rd. doi:https://doi.org/10.1001/archinte.159.5.445.
- Chopard R, Jimenez D, Serzian G, et al. Renal dysfunction improves risk stratification and may call for a change in the management of intermediate- and high-risk acute pulmonary embolism: results from a multicenter cohort study with external validation. Crit Care. 2021;25(1):57. doi:https://doi.org/10.1186/s13054-021-03458-z.
- Donze J, Le Gal G, Fine MJ, et al. Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008;100(5):943–948. doi:https://doi.org/10.1160/TH08-05-0285.
- Elias A, Mallett S, Daoud-Elias M, et al. Prognostic models in acute pulmonary embolism: a systematic review and meta-analysis. BMJ Open. 2016;6(4):e010324.
- Kohn CG, Mearns ES, Parker MW, et al. Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis. Chest. 2015;147(4):1043–1062.
- Righini M, Roy PM, Meyer G, et al. The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism. J Thromb Haemost. 2011;9(10):2115–2117.
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J. 2020;41(4):543–603. doi:https://doi.org/10.1093/eurheartj/ehz405.
- Grifoni S, Olivotto I, Cecchini P, et al. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfunction. Circulation. 2000;101(24):2817–2822. doi:https://doi.org/10.1161/01.CIR.101.24.2817.
- Kucher N, Rossi E, De Rosa M, et al. Prognostic role of echocardiography among patients with acute pulmonary embolism and a systolic arterial pressure of 90 mm Hg or higher. Arch Intern Med. 2005;165(15):1777–1781.
- Coutance G, Cauderlier E, Ehtisham J, et al. The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care. 2011;15(2):R103.
- Pruszczyk P, Goliszek S, Lichodziejewska B, et al. Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism. JACC Cardiovasc Imaging. 2014;7(6):553–560. doi:https://doi.org/10.1016/j.jcmg.2013.11.004.
- Lobo JL, Holley A, Tapson V, et al. Prognostic significance of tricuspid annular displacement in normotensive patients with acute symptomatic pulmonary embolism. J Thromb Haemost. 2014;12(7):1020–1027. doi:https://doi.org/10.1111/jth.12589.
- Becattini C, Agnelli G, Vedovati MC, et al. Multidetector computed tomography for acute pulmonary embolism: diagnosis and risk stratification in a single test. Eur Heart J. 2011;32(13):1657–1663. doi:https://doi.org/10.1093/eurheartj/ehr108.
- Becattini C, Agnelli G, Germini F, et al. Computed tomography to assess risk of death in acute pulmonary embolism: a meta-analysis. Eur Respir J. 2014;43(6):1678–1690.
- George E, Kumamaru KK, Ghosh N, et al. Computed tomography and echocardiography in patients with acute pulmonary embolism: part 2: prognostic value. J Thorac Imaging. 2014;29(1):W7–12. doi:https://doi.org/10.1097/RTI.0000000000000048.
- Etesamifard N, Shirani S, Jenab Y, et al. Role of clinical and pulmonary computed tomography angiographic parameters in the prediction of short- and long-term mortality in patients with pulmonary embolism. Intern Emerg Med. 2016;11(3):405–413.
- Cote B, Jimenez D, Planquette B, et al. Prognostic value of right ventricular dilatation in patients with low-risk pulmonary embolism. Eur Respir J. 2017;50(6):1701611. doi:https://doi.org/10.1183/13993003.01611-2017.
- Becattini C, Vedovati MC, Agnelli G. Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation. 2007;116(4):427–433.
- Lankeit M, Friesen D, Aschoff J, et al. Highly sensitive troponin T assay in normotensive patients with acute pulmonary embolism. Eur Heart J. 2010;31(15):1836–1844. doi:https://doi.org/10.1093/eurheartj/ehq234.
- Lankeit M, Jimenez D, Kostrubiec M, et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation. 2011;124(24):2716–2724. doi:https://doi.org/10.1161/CIRCULATIONAHA.111.051177.
- Klok FA, Mos IC, Huisman MV. Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis. Am J Respir Crit Care Med. 2008;178(4):425–430.
- Lankeit M, Jimenez D, Kostrubiec M, et al. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism. Eur Respir J. 2014;43(6):1669–1677. doi:https://doi.org/10.1183/09031936.00211613.
- Vanni S, Socci F, Pepe G, et al. High plasma lactate levels are associated with increased risk of in-hospital mortality in patients with pulmonary embolism. Acad Emerg Med. 2011;18(8):830–835. doi:https://doi.org/10.1111/j.1553-2712.2011.01128.x.
- Vanni S, Viviani G, Baioni M, et al. Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the thrombo-embolism lactate outcome study. Ann Emerg Med. 2013;61(3):330–338. doi:https://doi.org/10.1016/j.annemergmed.2012.10.022.
- Vanni S, Jimenez D, Nazerian P, et al. Short-term clinical outcome of normotensive patients with acute PE and high plasma lactate. Thorax. 2015;70(4):333–338. doi:https://doi.org/10.1136/thoraxjnl-2014-206300.
- Ghanima W, Abdelnoor M, Holmen LO, et al. D-dimer level is associated with the extent of pulmonary embolism. Thromb Res. 2007;120(2):281–288.
- Klok FA, Djurabi RK, Nijkeuter M, et al. High D-dimer level is associated with increased 15-d and 3 months mortality through a more central localization of pulmonary emboli and serious comorbidity. Br J Haematol. 2008;140(2):218–222. doi:https://doi.org/10.1160/TH06-07-0416.
- Agterof MJ, van Bladel ER, Schutgens RE, et al. Risk stratification of patients with pulmonary embolism based on pulse rate and D-dimer concentration. Thromb Haemost. 2009;102(4):683–687. doi:https://doi.org/10.1160/TH09-04-0229.
- Aujesky D, Roy PM, Guy M, et al. Prognostic value of D-dimer in patients with pulmonary embolism. Thromb Haemost. 2006;96(4):478–482.
- Stein PD, Janjua M, Matta F, et al. Prognostic value of D-dimer in stable patients with pulmonary embolism. Clin Appl Thromb Hemost. 2011;17(6):E183–5.
- Kline JA, Zeitouni R, Marchick MR, et al. Comparison of 8 biomarkers for prediction of right ventricular hypokinesis 6 months after submassive pulmonary embolism. Am Heart J. 2008;156(2):308–314.
- Scherz N, Labarere J, Mean M, et al. Prognostic importance of hyponatremia in patients with acute pulmonary embolism. Am J Respir Crit Care Med. 2010;182(9):1178–1183.
- Ng AC, Chow V, Yong AS, et al. Prognostic impact of the Charlson comorbidity index on mortality following acute pulmonary embolism. Respiration. 2013;85(5):408–416.
- Uhm JS, Jung HO, Kim CJ, et al. Comparison of clinical and imaging characteristics and outcomes between provoked and unprovoked acute pulmonary embolism in Koreans. J Korean Med Sci. 2012;27(11):1347–1353. doi:https://doi.org/10.3346/jkms.2012.27.11.1347.
- Abul Y, Karakurt S, Ozben B, et al. C-reactive protein in acute pulmonary embolism. J Investig Med. 2011;59(1):8–14.
- Wyzgal A, Koc M, Pacho S, et al. Plasma copeptin for short term risk stratification in acute pulmonary embolism. J Thromb Thrombolysis. 2016;41(4):563–568. https://doi.org/10.1007/s11239-015-1284-5.
- Lankeit M, Friesen D, Schafer K, et al. A simple score for rapid risk assessment of non-high-risk pulmonary embolism. Clin Res Cardiol. 2013;102(1):73–80.
- Kaczynska A, Pelsers MM, Bochowicz A, et al. Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism. Clin Chim Acta. 2006;371(1–2):117–123.
- Boscheri A, Wunderlich C, Langer M, et al. Correlation of heart-type fatty acid-binding protein with mortality and echocardiographic data in patients with pulmonary embolism at intermediate risk. Am Heart J. 2010;160(2):294–300. doi:https://doi.org/10.1016/j.ahj.2010.05.010.
- Puls M, Dellas C, Lankeit M, et al. Heart-type fatty acid-binding protein permits early risk stratification of pulmonary embolism. Eur Heart J. 2007;28(2):224–229. doi:https://doi.org/10.1093/eurheartj/ehl405.
- Dellas C, Puls M, Lankeit M, et al. Elevated heart-type fatty acid-binding protein levels on admission predict an adverse outcome in normotensive patients with acute pulmonary embolism. J Am Coll Cardiol. 2010;55(19):2150–2157. doi:https://doi.org/10.1016/j.jacc.2009.10.078.
- Lankeit M, Kempf T, Dellas C, et al. Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism. Am J Respir Crit Care Med. 2008;177(9):1018–1025. doi:https://doi.org/10.1164/rccm.200712-1786OC.
- Becattini C, Agnelli G, Lankeit M, et al. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. Eur Respir J. 2016;48(3):780–786. doi:https://doi.org/10.1183/13993003.00024-2016.
- Barco S, Mahmoudpour SH, Planquette B, et al. Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2019;40(11):902–910.
- Becattini C, Maraziti G, Vinson DR, et al. Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis. Eur Heart J. 2021;42(33):3190–3199. doi:https://doi.org/10.1093/eurheartj/ehab329.
- Bova C, Sanchez O, Prandoni P, et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J. 2014;44(3):694–703. doi:https://doi.org/10.1183/09031936.00006114.
- Fernandez C, Bova C, Sanchez O, et al. Validation of a Model for Identification of Patients at Intermediate to High Risk for Complications Associated With Acute Symptomatic Pulmonary Embolism. Chest. 2015;148(1):211–218. doi:https://doi.org/10.1378/chest.14-2551.
- Bova C, Vanni S, Prandoni P, et al. A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism. Thromb Res. 2018;165:107–111.
- Dellas C, Tschepe M, Seeber V, et al. A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism. Thromb Haemost. 2014;111(5):996–1003. doi:https://doi.org/10.1160/TH13-08-0663.
- Hobohm L, Hellenkamp K, Hasenfuss G, et al. Comparison of risk assessment strategies for not-high-risk pulmonary embolism. Eur Respir J. 2016;47(4):1170–1178.
- Barrios D, Rosa-Salazar V, Morillo R, et al. Prognostic Significance of Right Heart Thrombi in Patients With Acute Symptomatic Pulmonary Embolism: Systematic Review and Meta-analysis. Chest. 2017;151(2):409–416. doi:https://doi.org/10.1016/j.chest.2016.09.038.
- Giri J, Sista AK, Weinberg I, et al. Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. Circulation. 2019;140(20):e774–e801. doi:https://doi.org/10.1161/CIR.0000000000000707.
- Howard L, Barden S, Condliffe R, et al. British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE). Thorax. 2018;73(Suppl 2):ii1–ii29. doi:https://doi.org/10.1136/thoraxjnl-2018-211539.
- National Institute for Health and Care Excellence (NICE). Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NICE guideline 158). 2020. [Accessed 2022 January 28]. Available from: https://www.nice.org.uk/guidance/ng158.
- Konstantinides SV, Torbicki A, Agnelli G, et al. ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033-69, 69a–69k. doi:https://doi.org/10.1093/eurheartj/ehu283.
- Moor J, Baumgartner C, Mean M, et al. Validation of the 2019 European Society of Cardiology Risk Stratification Algorithm for Pulmonary Embolism in Normotensive Elderly Patients. Thromb Haemost. 2021;121(12):1660–1667. doi:https://doi.org/10.1055/a-1475-2263.
- Ortel TL, Neumann I, Ageno W, et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–4738. doi:https://doi.org/10.1182/bloodadvances.2020001830.
- Marti C, John G, Konstantinides S, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605–614. doi:https://doi.org/10.1093/eurheartj/ehu218.
- Sharifi M, Bay C, Skrocki L, et al. Moderate pulmonary embolism treated with thrombolysis (from the “MOPETT” Trial). Am J Cardiol. 2013;111(2):273–277.
- Kiser TH, Burnham EL, Clark B, et al. Half-Dose Versus Full-Dose Alteplase for Treatment of Pulmonary Embolism. Crit Care Med. 2018;46(10):1617–1625. doi:https://doi.org/10.1097/CCM.0000000000003288.
- Kucher N, Boekstegers P, Muller OJ, et al. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism. Circulation. 2014;129(4):479–486. doi:https://doi.org/10.1161/CIRCULATIONAHA.113.005544.
- Zondag W, Mos IC, Creemers-Schild D, et al. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost. 2011;9(8):1500–1507. doi:https://doi.org/10.1111/j.1538-7836.2011.04388.x.
- Vanni S, Becattini C, Nazerian P, et al. Early discharge of patients with pulmonary embolism in daily clinical practice: A prospective observational study comparing clinical gestalt and clinical rules. Thromb Res. 2018;167:37–43.
- Roy PM, Penaloza A, Hugli O, et al. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial. Eur Heart J. 2021;42(33):3146–3157. doi:https://doi.org/10.1093/eurheartj/ehab373.
- Aujesky D, Roy PM, Verschuren F, et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011;378(9785):41–48. doi:https://doi.org/10.1016/S0140-6736(11)60824-6.
- den Exter Pl, Zondag W, Klok FA, et al. Efficacy and Safety of Outpatient Treatment Based on the Hestia Clinical Decision Rule with or without N-Terminal Pro-Brain Natriuretic Peptide Testing in Patients with Acute Pulmonary Embolism. A Randomized Clinical Trial. Am J Respir Crit Care Med. 2016;194(8):998–1006. doi:https://doi.org/10.1164/rccm.201512-2494OC.
- Barco S, Schmidtmann I, Ageno W, et al. Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial. Eur Heart J. 2020;41(4):509–518. https://doi.org/10.1093/eurheartj/ehz367.
- Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960;1(7138):1309–1312.
- Kresoja KP, Ebner M, Rogge NIJ, et al. Prediction and prognostic importance of in-hospital major bleeding in a real-world cohort of patients with pulmonary embolism. Int J Cardiol. 2019;290:144–149.
- Zhang Z, Lei J, Zhai Z, et al. Comparison of prediction value of four bleeding risk scores for pulmonary embolism with anticoagulation: A real-world study in Chinese patients. Clin Respir J. 2019;13(3):139–147. doi:https://doi.org/10.1111/crj.12993.
- Carrier M, Le Gal G, Wells PS, et al. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med. 2010;152(9):578–589.
- van der Hulle T, Kooiman J, den Exter Pl, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost. 2014;12(3):320–328.
- Prandoni P, Trujillo-Santos J, Sanchez-Cantalejo E, et al. Major bleeding as a predictor of mortality in patients with venous thromboembolism: findings from the RIETE Registry. J Thromb Haemost. 2010;8(11):2575–2577. doi:https://doi.org/10.1111/j.1538-7836.2010.04039.x.
- Skowronska M, Furdyna A, Ciurzynski M, et al. D-dimer levels enhance the discriminatory capacity of bleeding risk scores for predicting in-hospital bleeding events in acute pulmonary embolism. Eur J Intern Med. 2019;69:8–13.
- Chopard R, Piazza G, Falvo N, et al. An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism: The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score. Chest. 2021;160(5):1832–1843. doi:https://doi.org/10.1016/j.chest.2021.06.048.
- Jara-Palomares L, Jimenez D, Bikdeli B, et al. Derivation and validation of a clinical prediction rule for thrombolysis-associated major bleeding in patients with acute pulmonary embolism: the BACS score. Eur Respir J. 2020;56(6):2002336. doi:https://doi.org/10.1183/13993003.02336-2020.
- Chatterjee S, Weinberg I, Yeh RW, et al. Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score. Thromb Haemost. 2017;117(2):246–251. doi:https://doi.org/10.1160/TH16-07-0588.
- Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2Suppl):e419S–e96S. doi:https://doi.org/10.1378/chest.11-2301.